Article
Gene polymorphism and serum level of RANKL among patients with rheumatoid arthritis: a systematic review and meta-analysis.
Cellular and molecular biology (Noisy-le-Grand, France) - 31 Mar 2026
Salajegheh Pouria, Salajegheh Amirali, Yazdi Farzaneh
Abstract excerpt
Receptor activator of nuclear factor-κB ligand (RANKL) is a key mediator linking inflammation to osteoclast activation and bone erosion in rheumatoid arthritis (RA). Evidence on circulating RANKL levels and RANKL (TNFSF11) polymorphisms in RA has been inconsistent. Web of Science, Scopus, and PubMed were searched from inception to December 2025 for clinical studies comparing patients with RA and healthy controls...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
